LTRN · Lantern Pharma Inc.
$2.65
+0.14 (+5.58%)
At close · Jul 30
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the existence of substantial doubt regarding our ability to continue as a going concern in the absence of obtaining substantial additional funding”View the 10-Q filed May 15, 2026
Market Cap
$28.37M
Shares
11.30M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-10 | 65 | $3.35 | $218 |
| 2026-07-08 | 2,514 | $3.57 | $8,975 |
| 2026-07-02 | 59 | $4.02 | $237 |
| 2026-06-26 | 1,018 | $3.67 | $3,736 |
| 2026-06-25 | 6,278 | $3.95 | $24,798 |
| 2026-06-17 | 21,868 | $3.91 | $85,504 |
| 2026-06-15 | 333 | $3.88 | $1,292 |
| 2026-06-12 | 1,781 | $4.07 | $7,249 |
| 2026-06-11 | 2,389 | $3.88 | $9,269 |
| 2026-06-10 | 2,903 | $3.81 | $11,060 |
| 2026-06-09 | 9,909 | $3.75 | $37,159 |
| 2026-06-08 | 1,248 | $3.59 | $4,480 |
| 2026-06-05 | 9,480 | $3.79 | $35,929 |
| 2026-06-04 | 629 | $3.40 | $2,139 |
| 2026-06-02 | 255 | $3.74 | $954 |
| 2026-05-29 | 16,782 | $3.50 | $58,737 |
| 2026-05-26 | 17 | $3.50 | $60 |
| 2026-05-22 | 270 | $3.32 | $896 |
| 2026-05-20 | 9,746 | $3.09 | $30,115 |
| 2026-05-19 | 22,812 | $3.00 | $68,436 |
| 2026-05-18 | 27,212 | $3.14 | $85,446 |
| 2026-05-15 | 20,998 | $3.13 | $65,724 |
| 2026-05-14 | 23,455 | $2.51 | $58,872 |
| 2026-05-13 | 258 | $2.06 | $531 |
| 2026-05-12 | 2,503 | $2.09 | $5,231 |
| 2026-05-11 | 311 | $2.10 | $653 |
| 2026-05-08 | 636 | $2.04 | $1,297 |
| 2026-05-06 | 5,397 | $2.16 | $11,658 |
| 2026-05-05 | 7,835 | $2.23 | $17,472 |
Showing 1–29 of 29 settlements